✦ LIBER ✦

CGP 49823, a novel, non-peptidic NK-1 receptor antagonist: in vitro pharmacology

✍ Scribed by K. Hauser; J. Heid; L. Criscione; F. Brugger; S. Ofner; S. Veenstra; W. Schilling

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

CGP 49823, a novel NK1 receptor antagoni

✍ A. Vassout; M. Schaub; C. Gentsch; S. Ofner; W. Schilling; S. Veenstra 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 129 KB

SAR of 2-benzyl-4-aminopiperidines: CGP

✍ Silvio Ofner; Kathleen Hauser; Walter Schilling; Annick Vassout; Siem J. Veenstr 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 331 KB

In vitro pharmacological profile of RPR1

✍ V. Fardin; A. Carruette; J. Menager; M. Bock; O. Flamand; F. Foucault; E. Heuill 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 125 KB

ChemInform Abstract: SAR of 2-Benzyl-4-a

✍ S. OFNER; K. HAUSER; W. SCHILLING; A. VASSOUT; S. J. VEENSTRA 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 34 KB

The potency of the novel tachykinin rece

✍ Mario F Pozza; Hans-Rudolf Olpe; Silvio Ofner; Catherine Schoeffel; Richard H Ev 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 164 KB

In vivo pharmacological properties of RP

✍ S.M. Moussaoui; F. Montier; A. Carruette; V. Fardin; A. Floch; C. Garret 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 132 KB